{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T01:40:24Z","timestamp":1721439624669},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Clinique et Biologique"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.tracli.2024.06.004","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T22:12:52Z","timestamp":1718230372000},"page":"157-161","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Personalized autologous stem cell harvesting improves patient collection outcomes"],"prefix":"10.1016","volume":"31","author":[{"given":"Gustavo de Carvalho","family":"Duarte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhua","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tracli.2024.06.004_b0005","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.bbmt.2013.10.013","article-title":"Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendations","volume":"20","author":"Giralt","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.tracli.2024.06.004_b0010","doi-asserted-by":"crossref","first-page":"e456","DOI":"10.1016\/S2352-3026(20)30099-5","volume":"7","author":"Cavo","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.tracli.2024.06.004_b0015","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMra052638","article-title":"Hematopoietic stem-cell transplantation","volume":"354","author":"Copelan","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tracli.2024.06.004_b0020","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.bbmt.2010.01.008","article-title":"The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of follicular lymphoma: an evidence-based review","volume":"16","author":"Oliansky","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.tracli.2024.06.004_b0025","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.bbmt.2015.02.022","article-title":"Role of cytotoxic therapy with hematopoietic cell transplantation in the treatment of Hodgkin lymphoma: guidelines from the American Society for Blood and Marrow Transplantation","volume":"21","author":"Perales","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.tracli.2024.06.004_b0030","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bbmt.2010.07.008","article-title":"The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large B cell lymphoma: update of the 2001 evidence-based review","volume":"17","author":"Oliansky","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.tracli.2024.06.004_b0035","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1111\/trf.16289","article-title":"Influence of laboratory procedures on postthawing cell viability and hematopoietic engraftment after autologous peripheral blood stem cell transplantation","volume":"61","author":"Belis\u00e1rio","year":"2021","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2024.06.004_b0040","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.clml.2019.12.018","article-title":"Adequate engraftment with lower hematopoietic stem cell dose","volume":"20","author":"Jeyaraman","year":"2020","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.tracli.2024.06.004_b0045","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/sj.bmt.1704926","article-title":"Association of post-thaw viable CD34+ cells and CFU-GM with time to hematopoietic engraftment","volume":"35","author":"Yang","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.tracli.2024.06.004_b0050","first-page":"61","article-title":"Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines","volume":"34","author":"Keeney","year":"1998","journal-title":"Int Soc Hematother Graft Eng Cytometry"},{"key":"10.1016\/j.tracli.2024.06.004_b0060","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/jha2.665","article-title":"A critical assessment of dose effects of post-thaw CD34 on autologous stem cell transplantation treatment of haematological malignancies","volume":"4","author":"Duarte","year":"2023","journal-title":"EJHaem"},{"key":"10.1016\/j.tracli.2024.06.004_b0065","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1111\/trf.16356","article-title":"A simplified CD34+ based preharvest prediction tool for HPC(A) collection","volume":"61","author":"Jacob","year":"2021","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2024.06.004_b0070","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.bbmt.2015.11.016","article-title":"Improved prediction of CD34+ cell yield before peripheral blood hematopoietic progenitor cell collection using a modified target value-tailored approach","volume":"22","author":"Sheppard","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.tracli.2024.06.004_b0075","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/j.1537-2995.2008.01687.x","article-title":"An algorithm based on peripheral CD34+ cells and hemoglobin concentration provides a better optimization of apheresis than the application of a fixed CD34 threshold","volume":"48","author":"Delamain","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2024.06.004_b0080","doi-asserted-by":"crossref","DOI":"10.1111\/vox.13410","article-title":"Prediction of blood volume to be processed to achieve a target number of CD34+ cells: development, validation and implementation of a formula","author":"Garc\u00eda-Garc\u00eda","year":"2023","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2024.06.004_b0085","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1423-0410.2006.00796.x","article-title":"Accurate prediction of autologous stem cell apheresis yields using a double variable-dependent method assures systematic efficiency control of continuous flow collection procedures","volume":"91","author":"Pierelli","year":"2006","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2024.06.004_b0090","doi-asserted-by":"crossref","unstructured":". EBMT. In: Carreras E, Dufour C, Mohty M, Kr\u00f6ger N, editors. The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies. Cham (CH): Springer; 2019.","DOI":"10.1007\/978-3-030-02278-5"},{"key":"10.1016\/j.tracli.2024.06.004_b0095","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/(SICI)1098-1101(1997)12:1<10::AID-JCA3>3.0.CO;2-D","article-title":"Safety of large-volume leukapheresis for collection of peripheral blood progenitor cells","volume":"12","author":"Reik","year":"1997","journal-title":"J Clin Apher"},{"key":"10.1016\/j.tracli.2024.06.004_b0100","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1111\/trf.17563","article-title":"Evaluating the efficiency and safety of large-volume leukapheresis using the Spectra Optia continuous mononuclear cell collection protocol for peripheral blood stem cell collection from healthy donors: a retrospective study","volume":"63","author":"Sumii","year":"2023","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2024.06.004_b0105","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/jca.20011","article-title":"Hematopoietic progenitor cell large volume leukapheresis (LVL) on the Fenwal Amicus blood separator","volume":"19","author":"Burgstaler","year":"2004","journal-title":"J Clin Apher"},{"key":"10.1016\/j.tracli.2024.06.004_b0110","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1537-2995.2004.04210.x","article-title":"Large-volume leukapheresis yields more viable CD34+ cells and colony-forming units than normal-volume leukapheresis, especially in patients who mobilize low numbers of CD34+ cells","volume":"45","author":"Abrahamsen","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2024.06.004_b0115","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/jca.10044","article-title":"Large-volume leukapheresis using femoral venous access for harvesting peripheral blood stem cells with the Fenwal CS 3000 Plus from normal healthy donors: predictors of CD34+ cell yield and collection efficiency","volume":"18","author":"Sohn","year":"2003","journal-title":"J Clin Apher"},{"key":"10.1016\/j.tracli.2024.06.004_b0120","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.bbmt.2010.11.021","article-title":"Transplanted CD34(+) cell dose is associated with long-term platelet count recovery following autologous peripheral blood stem cell transplant in patients with non-Hodgkin lymphoma or multiple myeloma","volume":"17","author":"Stiff","year":"2011","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Transfusion Clinique et Biologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782024000661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782024000661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T01:17:45Z","timestamp":1721438265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1246782024000661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1246782024000661"],"URL":"https:\/\/doi.org\/10.1016\/j.tracli.2024.06.004","relation":{},"ISSN":["1246-7820"],"issn-type":[{"value":"1246-7820","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Personalized autologous stem cell harvesting improves patient collection outcomes","name":"articletitle","label":"Article Title"},{"value":"Transfusion Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tracli.2024.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Soci\u00e9t\u00e9 fran\u00e7aise de transfusion sanguine (SFTS). Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}